Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha} mechanism involving neuroendocrine activation of follicle-stimulating hormone secretion.
Both testosterone and its nonaromatizable metabolite dihydrotestosterone (DHT) induce spermatogenesis in gonadotropin-deficient hpg mice. Surprisingly, because aromatization is not required, estradiol (E2) also induces spermatogenesis and increases circulating FSH in hpg mice, but the mechanism remains unclear. We studied E2-induced spermatogenesis in hpg mice on an estrogen receptor (ER)-alpha (hpg/alphaERKO) or ERbeta (hpg/betaERKO) knockout or wild-type ER (hpg/WT) background treated with subdermal E2 or DHT implants for 6 wk. In hpg/WT and hpg/betaERKO, but not hpg/alphaERKO mice, E2 increased testis and epididymal weight, whereas DHT-induced increases were unaffected by ERalpha or ERbeta inactivation. E2 but not DHT treatment increased serum FSH (but not LH) in hpg/WT and hpg/betaERKO but not hpg/alphaERKO hpg mice. DHT or E2 alone increased (premeiotic) spermatogonia and (meiotic) spermatocytes without significant change in Sertoli cell numbers. DHT alone increased postmeiotic spermatids, regardless of ER presence, compared with variable ERalpha-dependent E2 postmeiotic responses. An ERalpha-mediated effect was confirmed by treating hpg mice for 6 wk by subdermal selective ER-alpha (16alpha-LE(2)) or ERbeta (8beta-VE(2)) agonist implants. ERalpha (but not ERbeta) agonist increased testis and epididymal weight, Sertoli cell, spermatogonia, meiotic, and postmeiotic germ cell numbers. Only ERalpha agonist markedly increased serum FSH, whereas either agonist induced small rises in serum LH. Administration of ERalpha agonist or E2 in the presence of functional ERalpha induced prominent gene expression of specific Sertoli (Eppin, Rhox5) and Leydig cell (Cyp11a1, Hsd3b1) markers. We conclude that E2-induced spermatogenesis in hpg mice involves an ERalpha-dependent neuroendocrine mechanism increasing blood FSH and Sertoli cell function.
Allan
Charles M
CM
ANZAC Research Institute, Sydney, New South Wales 2139, Australia.
Couse
John F
JF
Simanainen
Ulla
U
Spaliviero
Jenny
J
Jimenez
Mark
M
Rodriguez
Karina
K
Korach
Kenneth S
KS
Handelsman
David J
DJ
D000818:Animals; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology*; D047628:Estrogen Receptor alpha / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D047629:Estrogen Receptor beta / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006062:Gonadotropins / Q000172:deficiency / Q000235:genetics; D007985:Leydig Cells / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009490:Neurosecretory Systems / Q000187:drug effects* / Q000378:metabolism*; D009929:Organ Size / Q000187:drug effects; D012669:Seminal Vesicles / Q000187:drug effects / Q000378:metabolism; D013091:Spermatogenesis / Q000187:drug effects* / Q000235:genetics; D013737:Testis / Q000187:drug effects / Q000378:metabolism
D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D006062:Gonadotropins; D013196:Dihydrotestosterone; D004958:Estradiol; D005640:Follicle Stimulating Hormone
Endocrinology. 1988 Mar;122(3):787-94
3125042
Endocrinology. 1978 Oct;103(4):1096-102
217666
J Androl. 2002 Nov-Dec;23(6):870-81
12399534
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13612-7
9811848
Steroids. 2007 Dec;72(14):914-22
17854852
Ernst Schering Res Found Workshop. 2004;(46):127-50
15248509
Endocrinology. 2000 Oct;141(10):3898-907
11014247
Endocrinology. 2003 Feb;144(2):509-17
12538611
Endocrinology. 2001 Jun;142(6):2213-20
11356665
Endocrinology. 2007 Feb;148(2):566-74
17068134
Endocrinology. 2000 Aug;141(8):2861-9
10919273
Endocrinology. 2000 Mar;141(3):1273-6
10698205
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1327-32
14745012
Reprod Fertil Dev. 2008;20(8):861-70
19007549
Proc Natl Acad Sci U S A. 2004 May 4;101(18):6876-81
15107499
J Mol Endocrinol. 2005 Dec;35(3):547-55
16326839
Endocrinology. 1999 Sep;140(9):3938-46
10465262
Gene. 2003 Jul 17;312:125-34
12909348
Endocrinology. 2009 Oct;150(10):4755-65
19574395
Biol Reprod. 2009 Sep;81(3):488-96
19439729
Mol Cell Endocrinol. 2001 Jun 10;178(1-2):57-63
11403895
Endocrinology. 1995 Dec;136(12):5311-21
7588276
Mol Endocrinol. 2004 Jul;18(7):1599-609
15105439
Endocrinology. 2005 May;146(5):2454-61
15661855
Cancer Res. 2009 Aug 1;69(15):6131-40
19638585
Cancer Res. 2005 Nov 15;65(22):10585-93
16288052
Neuroendocrinology. 1997 Feb;65(2):136-40
9067991
Endocrinology. 1997 Nov;138(11):4613-21
9348186
Endocrinology. 2000 May;141(5):1795-803
10803590
Development. 2004 Jan;131(2):459-67
14701682
J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):611-8
20144714
Clin Chim Acta. 2009 Nov;409(1-2):78-84
19747904
Mol Endocrinol. 2003 Jun;17(6):1039-53
12624116
Biol Reprod. 2005 Jan;72(1):78-85
15342359
J Mol Endocrinol. 2009 Apr;42(4):291-303
19136570
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7986-91
10393934
Endocrinology. 1996 Nov;137(11):4796-805
8895349
Reproduction. 2005 Jul;130(1):15-28
15985628
Biol Reprod. 2002 Apr;66(4):966-75
11906915
Nat Genet. 1997 Feb;15(2):201-4
9020850
Biol Reprod. 2000 Feb;62(2):310-7
10642567
Endocrinology. 2004 Apr;145(4):1587-93
14726449
Reprod Biol Endocrinol. 2008 Jan 29;6:4
18230131
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2433-8
18268329
Dev Biol. 1996 Nov 1;179(2):471-84
8903361
Am J Physiol Endocrinol Metab. 2009 May;296(5):E1022-8
19293333
Biol Reprod. 2000 Apr;62(4):886-94
10727257
Endocrinology. 2002 Dec;143(12):4922-33
12446620
Am J Anat. 1990 May;188(1):21-30
2111966
Reproduction. 2005 Nov;130(5):643-54
16264094
Development. 2000 Oct;127(19):4277-91
10976058
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15677-82
9861029
Endocrinology. 2009 Jun;150(6):2865-72
19196801